Chien-Hsiu Li

18PUBLICATIONS
19CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsMedical molecular engineering of nucleic acids and proteinsNanomaterials
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Jan 31, 2025
The prognostic and neuroendocrine implications of SLC25A29-mediated biomass signature in prostate cancer.

Chia-Chang Wu, Su-Wei Hu, Shao-Wei Dong

|Jan 29, 2024
Correction: CHRM4/AKT/MYCN upregulates interferon alpha-17 in the tumor microenvironment to promote neuroendocrine differentiation of prostate cancer.

Yu-Ching Wen, Van Thi Ngoc Tram, Wei-Hao Chen

|May 04, 2023
CHRM4/AKT/MYCN upregulates interferon alpha-17 in the tumor microenvironment to promote neuroendocrine differentiation of prostate cancer.

Yu-Ching Wen, Van Thi Ngoc Tram, Wei-Hao Chen

|Feb 14, 2023
The activation of EP300 by F11R leads to EMT and acts as a prognostic factor in triple-negative breast cancers.

Chien-Hsiu Li, Chih-Yeu Fang, Ming-Hsien Chan

|Jan 18, 2023
Overexpression of synaptic vesicle protein Rab GTPase 3C promotes vesicular exocytosis and drug resistance in colorectal cancer cells.

Yu-Chan Chang, Chien-Hsiu Li, Ming-Hsien Chan

|Jan 08, 2023
Gold Nanoparticles as a Biosensor for Cancer Biomarker Determination.

Chien-Hsiu Li, Ming-Hsien Chan, Yu-Chan Chang

Pageof 3

Frequent Collaborators

15 joint publications

Michael Hsiao

13 joint publications

Yu-Chan Chang

6 joint publications

Ming-Hsien Chan

5 joint publications

Chi-Long Chen